Medigene AG Analysis

Medigene Pink Sheet Analysis Notes

The company has price-to-book ratio of 0.92. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medigene AG had not issued any dividends in recent years. Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company was founded in 1994 and is headquartered in Munich, Germany. Medigene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 61 people.The quote for Medigene AG is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Medigene AG contact MBBS BS at 49 89 2000 330 or learn more at https://www.medigene.com.

Medigene AG Investment Alerts

Medigene Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medigene's market, we take the total number of its shares issued and multiply it by Medigene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Medigene Profitablity

The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Medigene Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Medigene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medigene shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Medigene. By using and applying Medigene Pink Sheet analysis, traders can create a robust methodology for identifying Medigene entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.